Validation of a prognostic scoring system for brain metastases with synchronous detection of primary cancers at initial consultation
A five-factor, 1-2 point score usable at initial consultation provides superior discrimination and parsimony in s-BM compared with established systems. External, multicenter validation is warranted.
Authors
- Naoki Kato (ORCID: https://orcid.org/0000-0001-5041-6985)
- Gota Saito
- Yuichi Murayama (ORCID: https://orcid.org/0000-0003-3490-385X)
- Tomoki Maetani (ORCID: https://orcid.org/0000-0001-5063-662X)
- Toshihide Tanaka (ORCID: https://orcid.org/0000-0002-6474-6317)
- Yohei Y. Yamamoto (ORCID: https://orcid.org/0000-0002-2166-3730)
- Yasuo Terasawa (ORCID: https://orcid.org/0000-0002-4535-8589)
- Yasuharu Akasaki (ORCID: https://orcid.org/0000-0001-8015-084X)
- Takuya Ishii (ORCID: https://orcid.org/0000-0001-9836-6390)
Institutions
- Jikei University School of Medicine (JP)
- The Jikei University Hospital (JP)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-11-17
- DOI
- https://doi.org/10.3389/fonc.2025.1617366
- Primary Topic
- Brain Metastases and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00